1 min read · 05 April 2010
Selecta Biosciences Inc., a Watertown, Mass.-based biopharma company focused on the development of immunomodulatory nanoparticles, has raised $15 million in Series C funding. OrbiMed Advisors led the round, and was joined by return backers Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The company previously raised $17.4 million.
3 min read · 05 April 2010
1 min read · 05 April 2010
Altheos Inc., a South San Francisco-based developer of small molecule drugs for unmet medical needs, has raised $20 million in Series A funding. Bay City Capital led the round, and was joined by Novo AS, Canaan Partners, Life Science Angels and Atheneos Capital. The company is initially focusing on compounds for glaucoma.
4 min read · 05 April 2010
L2C Inc., an Atlanta-based provider of consumer risk evaluation and identification solutions, has raised an undisclosed amount of Series A funding. The round was co-led by QED Investors and McGovern Enterprises.
3 min read · 05 April 2010
LearnVest Inc., operator of a personal finance website for women, has raised $4.5 million in Series A funding. Accel Partners led the round, and was joined by seed backers Richmond Management, Rose Tech Ventures and members of Circle Financial Group.
4 min read · 04 April 2010
Sakti3 Inc., an Ann Arbor, Mich.-based developer of lithium-ion batteries, has raised $7 million in Series B funding. Beringea was joined on the deal by return backer Khosla Ventures.
3 min read · 04 April 2010
1 min read · 04 April 2010
1 min read · 04 April 2010
2 min read · 04 April 2010